A Noblis subsidiary holds a spot on a potential $8 billion contract vehicle for support services to the Defense Department‘s Joint Program Executive Office for Chemical and Biological Defense.
The company said Thursday Noblis ESI aims to provide technology, subject matter experts and experience-based insight to help JPEO-CBD manage investments in chemical, biological, radiological and nuclear defense platforms through the Joint Enterprise-Research Development Acqusition Program.
Jordin Cohen, vice president of Noblis’ defense and homeland security business, said the company offers medical countermeasures, bioinformatics tools and detection analysis support to chemical and biological defense efforts.
“Noblis has supported JPEO-CBD since 2009, and we look forward to continuing to ensure that our nation’s warfighters remain capable and protected during all conditions,” Cohen added.
DoD announced the 170 awardees on the indefinite-delivery/indefinite-quantity contract in November of last year.